Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment. (Q51856262)
Jump to navigation
Jump to search
scientific article published on 13 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment. |
scientific article published on 13 January 2009 |
Statements
Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment. (English)
1 reference
1 reference
Jean-François Carrier
1 reference
Daniel Taussky
1 reference
Isabelle Gauthier
1 reference
Dominic Béliveau-Nadeau
1 reference
13 January 2009
1 reference
74
1 reference
4
1 reference
1128-1133
1 reference